About This Platform

RxLumen Sentinel was built by a pharmacist and market access professional working within Global Public Affairs' Health and Life Sciences practice, with one purpose: to give HLS colleagues faster, more rigorous access to the pharmaceutical market access intelligence that informs their daily work.

Pharmaceutical market access is an information-dense discipline. The data that matters — regulatory timelines, health technology assessment outcomes, price negotiation status, global pricing signals, patent and exclusivity positions — exists in the public domain. What has historically been missing is not the data itself but the interpretive framework that connects it to a coherent strategic message. RxLumen Sentinel addresses that gap. The platform aggregates publicly available data across multiple sources and applies a proprietary methodology to synthesise it into the kind of actionable, payer-oriented intelligence that market access teams need before they enter a critical engagement.

Ownership, Independence, and Intellectual Property

This platform was conceived, designed, built, funded, and is maintained entirely by its creator outside the normal course of their employment with Global Public Affairs. The development investment — including the domain registration, server infrastructure, software licensing, and ongoing maintenance costs — has been made personally by the creator, not by GPA or any affiliated entity. The intellectual property embodied in this platform, including the interpretive methodology, the analytical framework, and all associated tools and agents, is the proprietary and exclusive property of its creator.

The proprietary element of this platform is not the data — it is the methodology. The interpretive framework that determines which signals matter, how they relate to each other, what they mean for a specific drug at a specific moment in its access journey, and how they should be translated into a message that moves access forward represents original intellectual work. That work reflects years of clinical practice, pharmacoeconomic training, health technology assessment experience, and market access strategy. It is what distinguishes intelligence from information, and it belongs to the creator of this platform.

What This Platform Is Not

This platform is not a product or service of Global Public Affairs, and it should not be understood as representing GPA's views, analysis, or recommendations in any form. GPA has not reviewed, endorsed, or validated the content or analysis produced by this tool. The platform operates on independent infrastructure — it is not hosted on, connected to, or part of GPA's internal systems, networks, or technology environment — and GPA bears no responsibility for its operation, accuracy, or continuity.

This platform is not a consulting practice or commercial venture operating in competition with GPA or any other firm. It is a professional tool built in service of GPA's HLS practice. Any human advisory services associated with this platform are channelled through GPA's Health and Life Sciences team and handled through GPA's standard client engagement process. Nothing on this platform is offered or contracted independently of that arrangement.

Data and Confidentiality

The intelligence produced by RxLumen Sentinel is derived exclusively from publicly available data sources. No proprietary, confidential, or company-held information is collected, stored, or processed on this platform. GPA colleagues and clients should not enter, upload, or reference any confidential or proprietary information when using this tool. The platform is designed architecturally for public intelligence only, and it is not configured to receive, retain, or process information of any other kind.

How to Engage with the Analysis and Advisory Services

The strategic advisory services associated with this platform — including submission and strategy reviews, pre-engagement briefings, team alignment sessions, and message development — are available to GPA colleagues and clients through GPA's Health and Life Sciences team. These services are not offered or contracted independently through this website.

To request access to reports or analysis produced through this platform, or to enquire about engaging the HLS team's market access advisory services, please use the request form below. All requests submitted here are shared directly with GPA's HLS team and handled through GPA's standard client engagement process.